We serve Chemical Name:3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one CAS:69949-67-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one](https://a.dearchem.com/CAS2/69949-67-3.png)
Chemical Name:3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one
CAS.NO:69949-67-3
Synonyms:3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one
Molecular Formula:C11H9BrF3NO
Molecular Weight:308.09400
HS Code:2933790090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:20.31000
Exact Mass:306.98200
LogP:3.27060
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one Use and application,3-bromo-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one technical grade,usp/ep/jp grade.
Related News: As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. 4-(2,4-dimethyl-oxazol-5-yl)benzenesulfonyl chloride manufacturers Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 4-fluoro-5-((7-(2-methoxyethoxy)quinazolin-4-yl)amino)-2-methylphenol suppliers This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry. RNA (dengue virus 3 clone NID15-1A gene NS2B fragment) vendor & factory A strategic CDMO partner who can uphold a strong product manufacturing approach can positively influence timeline, quality, and costs of bringing the drug to market. ,After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million.
